Effect of Farnesyltransferase Inhibitors on SARS-CoV-2.
J Glob Antimicrob Resist
; 2022 Nov 30.
Article
in English
| MEDLINE | ID: covidwho-2286429
ABSTRACT
The emergence of SARS-CoV-2 in 2019 led to a severe pandemic situation. Treatment options are limited and the efficacy of vaccines decreases due to mutations in SARS-CoV-2 strains. Therefore, new treatment options are urgently needed, and computational compound screenings are used to predict drugs quickly. One of these screenings revealed farnesyltransferase inhibitors (FTIs) as potential candidates. We demonstrated that the FTIs lonafarnib and tipifarnib have an impact on SARS-CoV-2 Wildtype and the Delta variant. Both FTIs dose-dependently reduced morphological changes and the formation of cytopathic effects in SARS-CoV-2 infected Calu-3 cells.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
Topics:
Vaccines
/
Variants
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
J.jgar.2022.11.011
Similar
MEDLINE
...
LILACS
LIS